biotech · Recurrent Pericarditis · Acute Myocarditis · CRDL
Cardiol Therapeutics
Cardiol Therapeutics patent portfolio — 15 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 2265 Upper Middle Rd E, Suite 602, Greater Toronto Area, Ontario L6H 0G5, CA
- Founded
- 2017
- Employees
- 27
- Programs
- 11
- Drugs
- 31
- Patents
- 15
Cardiol Therapeutics patents
15 pharmaceutical patents indexed for Cardiol Therapeutics. 1 expire within 24 months.
Cardiol Therapeutics has 15 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 12419888
Methods of treating elevated plasma cholesterol
granted -
US 11844771
Methods of treating acute respiratory distress syndrome using colchicine
granted -
US 11795434
Engineered stem cells and cellular products produced and secreted by such cells, methods of preparing, and uses thereof
granted -
US 11639490
Device and method for producing and purifying exosomes
granted -
US 11529390
PCSK9 inhibitory polypolypeptides and methods of use
granted -
US 11400063
Early administration of low-dose colchicine after myocardial infarction
granted -
US 10788490
Dried cellulose-treated tissue for in-vitro complement activation assays and diagnostic kits
granted -
US 9789134
Agent for the selective adjustment of blood lipids
granted -
US 8729115
Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases
granted -
US 8703800
Nitrate and diazeniumdiolate derivatives of pioglitazone
granted -
US 8703098
Labelled adrenomedullin derivatives and their use for imaging and therapy
granted -
US 8475764
Labelled adrenomedullin derivatives and their use for imaging and therapy
granted -
US 8426597
Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
granted -
US 8030010
Method for detecting a biomarker of oxidative stress in a biological sample
granted -
US 7235534
Antisense strategy to modulate estrogen receptor response (ER α and/or ER β )
granted
Frequently asked questions
How many patents does Cardiol Therapeutics have?
15 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Cardiol Therapeutics patents expire?
1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.